Mien‐Chie Hung

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

163h-index98.9kcitations1.5kworks5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(163), RNA modifications and cancer(123), Monoclonal and Polyclonal Antibodies Research(115), Cancer-related Molecular Pathways(108), Cancer-related gene regulation(94)

Publications1.5k total

Targeting ephrin receptor A10 with antibody-drug conjugates for breast cancer
Cancer Letters·2025
YAP/TEAD-activated TAG synthesis and peroxidation in lipid droplets confer ROS resistance in cancer stem cells
Redox Biology·2025Open Access
Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort
European Journal of Cancer·2025
High subcutaneous nerve activity in noise-associated ventricular arrhythmias
Heart Rhythm·2025
Effects of an exercise program on chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer individuals receiving taxanes: a randomized controlled trial
Supportive Care in Cancer·2025
Figure S5 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Figure S9 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Table S2 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Figure S6 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Figure S7 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Table S1 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Figure S10 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Multiple reciprocal interactions within B-cell receptor and AKT signaling pathways regulate response to EZH2 inhibition in germinal center-derived diffuse large B-cell lymphoma
Blood·2025Open Access
Figure S8 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Figure S1 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Figure S12 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Figure S3 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Data from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Figure S2 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
Figure S4 from MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis
2025Open Access
page 1 of 77Next →

Frequent Co-authors

Weiya Xia(22), Gabriel N. Hortobágyi(12), Yongkun Wei(11), Dihua Yu(10), Chia‐Wei Li(9), Jung-Mao Hsu(9), Jennifer L. Hsu(8), Ayşegül A. Şahin(7), Jong‐Ho Cha(7), Hirohito Yamaguchi(7), Binhua P. Zhou(6), Li-Chuan Chan(6), Qingqing Ding(6), Seung-Oe Lim(5), Heng‐Huan Lee(5), Yun Wu(5), Dung‐Fang Lee(5), Bill Spohn(4), Sam S. Chang(4), Tae‐Wan Kim(4)